EUTM file information

018275129

INDUSTRIALIZING DRUG DISCOVERY


July 19, 2020

Trademark Summary

The trademark application INDUSTRIALIZING DRUG DISCOVERY was filed by Recursion Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). Application withdrawn.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 9 with Computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds.
  • The mark was filed in class 42 with following description of goods:
    1. Pharmaceutical research and development services
    2. Scientific research and development of pharmaceutical preparations
    3. Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments
    4. Contract research services in support of scientific research and development of pharmaceutical preparations
    5. Technical consultancy and services in relation to technical research in the field of pharmaceuticals
    6. Consultancy in relation to scientific research in the field of pharmaceuticals
    7. Providing medical research and scientific research information in the field of medicine and pharmaceuticals
    8. Drug discovery services
    9. Drug use discovery services
    10. Scientific and technological services namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials
    11. Software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds.